Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.

NCT04573595 · ClinicalTrials.gov registry record · NA

Fresenius Noninvasive Blood Pressure Validation

A NA study of Blood Pressure, sponsored by Fresenius Medical Care North America.

Completed
Registry status
NA
Development phase
159
Enrollment target
1
Study location

NCT04573595 is a NA study of Blood Pressure that has completed, run by Fresenius Medical Care North America. The registered enrollment target is 159 participants, below the 285-participant average among 101 other Blood Pressure trials with a reported enrollment target (44% lower). The trial reports 1 study location across 1 state.

View on ClinicalTrials.gov ↗

View your shortlist →

The verdict

NCT04573595, a NA study of Blood Pressure, has completed, sponsored by Fresenius Medical Care North America.

COMPLETED
Registry status
NA
Development phase
159 participants
Enrollment target
1
Study location

Study Summary

The purpose of this study to collect blood pressure measurement values from the blood pressure measurement device on the Fresenius machine as compared to the standard method.

Conditions Studied

Interventions

  • DEVICE Blood Pressure Measurement

Study Locations (1)

Colorado

  • Clinimark, Site ID#001 - Louisville

Trial Details

FieldValue
Enrollment Target 159 participants
Start Date 2020-09-17
Est. Completion 2020-12-04
Phase NA

What the Registry Record Tells You About NCT04573595

The ClinicalTrials.gov registry entry for NCT04573595 describes a study currently listed as completed, categorized as NA. The registered enrollment target is 159 participants, a figure that helps gauge the scale of data the investigators plan to collect, below the 285-participant average among 101 other Blood Pressure trials with a reported enrollment target (44% lower). The listed sponsor is Fresenius Medical Care North America, which has 13 total studies on file at ClinicalTrials.gov.

The record links to 1 condition, with Blood Pressure appearing as the primary indexed condition, and to 1 intervention - of which Blood Pressure Measurement is the first listed.

NCT04573595 reports 1 study location spanning 1 distinct geographic area - top geographies include Colorado.

Frequently Asked Questions

What is clinical trial NCT04573595 about?

NCT04573595 is a clinical study titled "Fresenius Noninvasive Blood Pressure Validation". The purpose of this study to collect blood pressure measurement values from the blood pressure measurement device on the Fresenius machine as compared to the standard method.

What is the current status of trial NCT04573595?

This trial is currently completed. It is a NA study. The enrollment target is 159 participants. The study started on 2020-09-17. Estimated completion is 2020-12-04.

What conditions does trial NCT04573595 study?

This clinical trial studies the following conditions: Blood Pressure.

What interventions are being tested in trial NCT04573595?

The interventions under investigation include: Blood Pressure Measurement (DEVICE).

Who is sponsoring clinical trial NCT04573595?

This trial is sponsored by Fresenius Medical Care North America, which has 13 total clinical trials registered on ClinicalTrials.gov.

Where is trial NCT04573595 being conducted?

This trial has 1 study location across Colorado. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.

Similar trials for Blood Pressure

Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.

Data sourced from official public datasets. See our methodology for details. Retrieved and formatted by PlainTrial Editorial

Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.